FDA: Pfizer vaccine benefits outweigh risks for children – report

The United States Food and Drug Administration (FDA) determined that benefits outweigh the risks and endorsed Pfizer-BioNTech’s coronavirus vaccine for children aged 5 to 11, The Washington Post reported.

In its analysis, the agency found that the jab proved highly effective in preventing symptomatic infections and caused no safety issues.

Breaking the News / NL